Enzymatica AB (publ) announced the nomination committee, in respect of the annual general meeting 2024, has been comprised of Mats Andersson (Abanico Invest AB as well as private holdings), Håkan Roos (Roosgruppen AB), Björn Algkvist (Fibonacci Growth Capital AB), Guðmundur Pálmason (Fortus hf.) and the chairman of the board, Bengt Baron. Björn Algkvist served as chairman of the Nomination Committee.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.08 SEK | -4.94% | -9.14% | -21.93% |
Apr. 25 | Enzymatica AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 27 | Enzymatica AB Announces Composition of Nomination Committee | CI |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.93% | 48.71M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- ENZY Stock
- News Enzymatica AB
- Enzymatica AB Announces Composition of Nomination Committee